Comparison

Imatinib Mesylate

Manufacturer Adooq
Category
Type Inhibitors
Specific against other
Amount 200mg
Item no. A10468-200
eClass 6.1 30220300
eClass 9.0 32160605
Available
Short Description
Imatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
Cas No
220127-57-1
Synonyms
Gleevec, Glivec, CGP-57148B, STI-571
Formula
C29H31N7O.CH4SO3
Solubilty
DMSO
Purity
>98%
Chemical Name
4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl]benzamide methanesulfonate
M. Wt.
589, 7
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Storage
2 years at -20C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Delivery expected until 5/30/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close